Zobrazeno 1 - 10
of 107
pro vyhledávání: '"B. Wiklund"'
Autor:
E. Wiebelhaus, P. Seguin, J.F. Leca, B.E. Sundström, H. Bodenmüller, L. Bellanger, T. Meier, M. Nap, B. Wiklund, C. Andrés, J. Hilgers, H. Bonfrer, A. van Dalen, A. Sjödin, Anders Johansson, Ann Erlandsson, T. van Wel, J. Brundell, Torgny Stigbrand, R. Einarsson
Publikováno v:
Tumor Biology. 22:4-10
In the first report of the TD5 workshop (TD5-1), the epitope specificities of 30 different monoclonal antibodies against cytokeratins 8, 18 and 19 were determined. This second report presents the immunohistochemical profiles of these antibodies using
Autor:
J. Elfström, T. Länne, M. Thomsen, H. Björkman, P-Å. Karlqvist, E. Ribbe, T. Bolin, G. Plate, P. Dalman, J. Stenbaek, Leif Spangen, Sadettin Karacagil, B. Wiklund, O. Forsberg, K-A. Ängquist, L. Johansen, David Bergqvist
Publikováno v:
European Journal of Vascular and Endovascular Surgery. 11(4):425-428
Aim:To investigate a series of patients with secondary aortoenteric fistulas and compare it with a previous series (1985–93 vs. 1973–84).Design:Retrospective study of medical records.Setting:Sixteen vascular surgical centres in Sweden.Patients:Tw
Autor:
Ingemar Björkhem, Jukka T. Salonen, B Wiklund, Ulf Diczfalusy, Susanna Dzeletovic, Kristiina Nyyssönen, N Pettersson, A Babiker, Mats Eriksson
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 65(5)
Extrahepatic sterol 27-hydroxylase (CYP27) appears to have a role in the elimination of excess cholesterol from various cells, particularly macrophages, and there is a net flux of 27-hydroxyycholesterol and its metabolites from different extrahepatic
Autor:
B, Wiklund
Publikováno v:
Lakartidningen. 98(48)
Publikováno v:
Lakartidningen. 98(36)
In the new guidelines from the Swedish Medical Products Agency, an aggressive approach is recommended for the treatment of hyperlipidemia in all patients with manifest atherosclerotic disease. Patients with intermittent claudication should therefore
Publikováno v:
Anticancer research. 19(3A)
In this study we investigated if the newly developed monoclonal antibodies against Cytokeratin 8 and 18 fragments (Cyk 8/18) have prognostic information in patients with non-small cell lung cancer (NSCLC).Serum from 69 patients with NSCLC was investi
Autor:
E. Wiebelhaus, P. Seguin, Birgitta Wireklint Sundström, A. van Dalen, C. Andrés, M. Levi, H. Bonfrer, J.F. Leca, J. Hilgers, M. Nap, Lisbeth Ärlestig, H. Bodenmüller, T. Meier, B. Wiklund, M. Bishr Omary, Ann Erlandsson, R. Einarsson, A. Sjödin, J. Brundell, Torgny Stigbrand, L. Bellanger, K. Nustad, A. Johansson
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 19(2)
The epitope specificities of 30 monoclonal antibodies (MAbs) against the most common human cytokeratins. i.e., Nos. 8, 18, and 19, in epithelial cells were investigated in the ISOBM TD-5 Workshop. Seven research groups from universities or companies
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Å Sillén, B Wiklund, Gunnar Wagenius, Ola Brodin, Kristina Lamberg, Daniel Brattström, Michael Bergqvist, P. Hesselius
Publikováno v:
European Journal of Cancer. 35:S260
Publikováno v:
The EMBO Journal. 3:2707-2714
Because of the broad clinical interest which tissue polypeptide antigen (TPA) has attracted as a tumor marker, human cell lines and human tissues have been analyzed for TPA expression using immunofluorescence microscopy. Epithelial cell lines includi